CRF Health has launched version 2 of TrialConsent, offering new enhancements to the industry’s first electronic informed consent solution with a fully embedded design tool.
The solution promotes better comprehension, compliance and retention rates while reducing regulatory risk. TrialConsent 2.0 offers an improved user interface with enhanced navigation for participants and site personnel.
“CRF Health is committed to simplifying the path to approval, streamlining complex processes and delivering reliable results for superior clinical trial outcomes. The forward-thinking architecture behind TrialConsent 2.0 allows the platform to be fully integrated with an existing eCOA solution or delivered as a stand-alone solution, simplifying and providing consistency, control and flexibility to the informed consent process,” Rachael Wyllie, CEO said. “Comprehensive reporting enables study teams and ethics committees to monitor the consent status of sites and participants, track and analyze compliance and ultimately make smarter decisions. We firmly believe this advancement represents a step change in the way Informed Consent can be managed throughout its lifecycle.”